Physician

Adriana Maria Villa, M.D

According to 2025 Medicare claims, Adriana Villa, M.D (NPI: 1114137809) practices dermatology in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is VITALMD GROUP HOLDING LLC (NPI: 1871572032; TIN: 542129332) and primary practice location at 33133-4214. Villa is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Villa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 141 traditional Medicare patients, billed 412 HCPCS/CPT codes, and received $28,087 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 486 prescription claims across 172 beneficiaries totaling $12,695 in drug costs, led by Metronidazole (Metronidazole). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $13,859 to $28,087. In contrast, Part D prescription costs have fallen sharply in recent years, from $69,711 to $12,695. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$14K$28K2015 Medicare payment: $13,859 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $14,658 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $13,909 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $20,262 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $20,208 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $17,501 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $21,424 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $23,579 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $25,246 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $28,087 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201575230$13,859
201669214$14,658
201780225$13,909
2018107293$20,262
201997288$20,208
2020103267$17,501
2021116325$21,424
2022126329$23,579
2023135365$25,246
2024141412$28,087

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$35K$70K2015 Drug cost: $69,711 (USD; Tot_Drug_Cst)2016 Drug cost: $65,499 (USD; Tot_Drug_Cst)2017 Drug cost: $51,107 (USD; Tot_Drug_Cst)2018 Drug cost: $44,595 (USD; Tot_Drug_Cst)2019 Drug cost: $39,004 (USD; Tot_Drug_Cst)2020 Drug cost: $29,264 (USD; Tot_Drug_Cst)2021 Drug cost: $21,736 (USD; Tot_Drug_Cst)2022 Drug cost: $14,365 (USD; Tot_Drug_Cst)2023 Drug cost: $30,611 (USD; Tot_Drug_Cst)2024 Drug cost: $12,695 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015303976$69,711
20163131,127$65,499
20173051,137$51,107
2018293991$44,595
2019315990$39,004
2020241917$29,264
2021259869$21,736
2022228664$14,365
2023226679$30,611
2024172486$12,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6674$92
17110Destruction of skin growth, 1-14 growths4047$87
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more2121$78
11102Biopsy of related skin growth, first growth4146$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5370$61

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MetronidazoleMetronidazole16425$1,654
Gentamicin SulfateGentamicin Sulfate43493$1,135
FluorouracilFluorouracil19545$940
NystatinNystatin721,754$842
CiclopiroxCiclopirox27770$812

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Adriana Maria Villa, M.D?

Tedicare shows public-source Medicare data for Adriana Maria Villa, M.D (NPI 1114137809), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adriana Maria Villa, M.D have ACO affiliation data?

Adriana Maria Villa, M.D is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Adriana Maria Villa, M.D?

Adriana Maria Villa, M.D is linked to VITALMD GROUP HOLDING LLC (billing NPI 1871572032) in the available physician profile data.

Does Adriana Maria Villa, M.D have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.